[Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Ein Konsensusstatement].

Lindner, C, Dierneder, J, Pall, G, Pirich, C, Hoffmann, M, Raderer, M, Becherer, A, Niederle, B, Lipp, R, Lind, P, Gallowitsch, H, Romeder, F, Virgolini, I. Nuklearmedizin. 2015, 54(3): 125-130.

B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.

Zaborsky, N, Holler, C, Geisberger, R, Asslaber, D, Gassner, FJ, Egger, V, PiГ±Гіn-Hofbauer, J, Kocher, T, Hartmann, TN, Greil, R, Egle, A. Haematologica. 2015, 100(8): e307-e310.

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.

Kern, D, Regl, G, Hofbauer, SW, Altenhofer, P, Achatz, G, Dlugosz, A, Schnidar, H, Greil, R, Hartmann, TN, Aberger, F. Oncogene. 2015, 34(42): 5341-5351.

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin“s lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.

Behringer, K, Goergen, H, Hitz, F, Zijlstra, JM, Greil, R, Markova, J, Sasse, S, Fuchs, M, Topp, MS, Soekler, M, Mathas, S, Meissner, J, Wilhelm, M, Koch, P, Lindemann, H, Schalk, E, Semrau, R, Kriz, J, Vieler, T, Bentz, M, Lange, E, Mahlberg, R, Hassler, A, Vogelhuber, M, Hahn, D, Mezger, J, Krause, SW, Skoetz, N, Böll, B, von Tresckow, B, Diehl, V, Hallek, M, Borchmann, P, Stein, H, Eich, H, Engert, A. Lancet. 2015, 385(9976):1418-1427.

IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer-Results of a case series after 5-year follow-up.

Fastner, G, Reitsamer, R, Ziegler, I, Zehentmayr, F, Fussl, C, Kopp, P, Peintinger, F, Greil, R, Fischer, T, Deutschmann, H, Sedlmayer, F. Int J Cancer. 2015, 136(5): 1193-1201.

Lapatinib-plus-Pegylated Liposomal Doxorubicin in Advanced HER2-positive Breast Cancer Following Trastuzumab: A Phase II Trial.

Pircher, M, Mlineritsch, B, Fridrik, MA, Dittrich, C, Lang, A, Petru, E, Weltermann, A, Thaler, J, Hufnagl, C, Gampenrieder, SP, Rinnerthaler, G, Ressler, S, Ulmer, H, Greil, R. Anticancer Res. 2015, 35(1): 517-521.

A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?.

Schlick, K, Troch, M, Placher-Sorko, G, Faber, V, Neureiter, D, Berghoff, AS, Preusser, M, Greil, R, Hopfinger, G. Ann Hematol. 2015, 94(2): 345-346.

Adipocyte-derived players in hematologic tumors: useful novel targets?.

Jöhrer, K, Ploner, C, Thangavadivel, S, Wuggenig, P, Greil, R. Expert Opin Biol Ther. 2015, 15(1): 61-77.

Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.

Stadlmayr, A, Aigner, E, Huber-Schönauer, U, Niederseer, D, Zwerina, J, Husar-Memmer, E, Hohla, F, Schett, G, Patsch, W, Datz, C. Acta Diabetol. 2015, 52(1):39-46.

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Berghoff, AS, Ilhan-Mutlu, A, Dinhof, C, Magerle, M, Hackl, M, Widhalm, G, Hainfellner, JA, Dieckmann, K, Pichler, J, Hutterer, M, Melchardt, T, Bartsch, R, Zielinski, CC, Birner, P, Preusser, M. Neuropathol Appl Neurobiol. 2015, 41(2):e41-e55.